WuXi Biologics Germany GmbH currently employs a growing team of more than 360 highly skilled people at both sites in Leverkusen and Wuppertal. Dr.Chris Chen, CEO of WuXi Biologics, commented, "The investment in our facilities inGermanywill add new capacity and enhance our existing manufact...
Germany and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development and manufacturing solutions. As of December 31, 2022, WuXi Biologics is supporting 588 integrated client projects, including 17 in commercial...